Average Co-Inventor Count = 7.59
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (30 from 329 patents)
2. Genentech, Inc. (2 from 3,221 patents)
3. Astrazeneca Ab (1 from 1,500 patents)
30 patents:
1. 10758542 - Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors
2. 10647730 - Macrocyclic compounds as TRK kinase inhibitors
3. 10323022 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
4. 10251889 - Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
5. 9902741 - Macrocyclic compounds as TRK kinase inhibitors
6. 9878997 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
7. 9840519 - Macrocyclic compounds as TRK kinase inhibitors
8. 9796724 - Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
9. 9782415 - Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
10. 9750744 - Macrocyclic compounds as Trk kinase inhibitors
11. 9718822 - Macrocyclic compounds as Trk kinase inhibitors
12. 9682979 - Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitors
13. 9562055 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors
14. 9493476 - Macrocyclic compounds as trk kinase inhibitors
15. 8933084 - Macrocyclic compounds as Trk kinase inhibitors